Xtant Medical Holdings XTNT Income Statement (2010-2025)

NYSE XTNT
$0.34 -0.04 (-11.34%)
As of: Sep 9, 2026 · 3:58 PM EDT
Reported Financials

Xtant Medical Holdings Quarterly Income Statement

Periods 63 quarters
Latest Dec 2025

Xtant Medical Holdings reported net income of $0.37M for the quarter ended Dec 2025. This income statement covers 63 quarters of results from Jun 2010 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue
12.54M14.97M13.78M13.97M12.96M15.28M14.46M15.27M17.94M20.23M25.02M28.11M27.87M29.94M27.94M31.51M32.90M35.41M33.26M
Cost of RevenueCost of Rev
4.45M5.46M6.59M6.28M5.40M6.90M6.57M6.96M7.41M7.77M9.69M10.97M10.57M11.36M11.63M15.49M12.66M11.13M11.26M
Gross Profit
8.09M9.52M7.19M7.70M7.56M8.37M7.90M8.31M10.54M12.46M15.33M17.14M17.30M18.58M16.31M16.02M20.24M24.28M21.99M17.75M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D
4.86M5.59M5.27M5.31M5.21M5.64M5.84M5.83M7.05M8.72M11.09M11.58M12.46M13.18M11.89M11.68M11.20M11.62M11.75M
Selling, General & AdministrativeSG&A
3.03M4.17M3.11M4.14M3.97M3.80M3.73M3.97M4.88M4.95M7.14M8.87M7.79M7.71M7.49M5.70M7.53M7.48M7.07M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
0.21M0.24M0.26M0.15M0.21M0.24M0.23M0.23M0.17M0.18M0.49M0.49M0.53M0.64M0.70M0.52M0.44M0.57M0.63M
Operating ExpensesOpex
8.10M10.01M8.64M9.61M9.39M9.67M9.80M10.03M12.11M13.85M18.72M20.94M20.77M21.53M20.08M17.91M19.18M19.66M19.45M
Operating IncomeOp. Inc
-0.01M-0.49M-1.45M-1.91M-1.83M-1.30M-1.90M-1.72M-1.58M-1.39M-3.38M-3.81M-3.47M-2.95M-3.78M-1.88M1.06M4.62M2.54M
EBIT
-0.01M-0.49M-1.45M-1.91M-1.83M-1.30M-1.90M-1.72M-1.58M-1.39M-3.38M-3.81M-3.47M-2.95M-3.78M-1.88M1.06M4.62M2.54M2.32M
Non-operating items
Non Operating Interest Expenses
0.00M0.20M0.33M0.47M0.36M0.40M0.44M0.49M0.57M0.79M0.76M0.82M0.83M0.99M1.20M1.13M1.04M1.00M0.90M0.72M
Interest & Investment IncomeInt & Inv Inc
0.09M-0.00M0.05M0.02M
Other Non Operating IncomeOther Non Op Inc.
-0.04M0.12M0.03M-0.24M0.02M0.18M-0.06M
Non Operating IncomeNon Op. Inc.
-0.00M-0.20M-0.33M-0.47M-0.36M-0.40M-0.44M-0.46M-0.49M-0.79M10.32M0.08M-0.86M-0.88M-1.19M-1.26M-1.03M-0.82M-0.98M
Net income details
EBT
-0.01M-0.69M-1.77M-2.38M-2.19M-1.70M-2.34M-2.19M-2.06M-2.18M6.93M-3.73M-4.33M-3.83M-4.96M-3.14M0.03M3.81M1.56M1.60M
Tax ProvisionsTaxes
0.02M0.04M0.03M-1.11M0.02M0.01M0.01M-1.81M0.01M0.01M-2.30M0.58M0.07M0.04M0.06M0.02M-0.03M0.26M0.26M1.54M
Profit After TaxPAT
-0.03M-0.73M-1.80M-2.28M-2.21M-1.71M-2.35M-11.69M-2.08M-2.19M9.23M12.23M-4.40M-3.86M-5.02M-3.51M0.06M3.91M1.31M0.37M
Income from Continuing OperationsIncome (Continuing)
-0.03M-0.73M-1.80M-1.26M-2.21M-1.71M-2.35M-0.37M-2.08M-2.19M9.23M-4.30M-4.40M-3.86M-5.02M-3.17M0.06M3.55M1.31M0.06M
Consolidated Net IncomeConsol Net Inc.
-0.03M-0.73M-1.80M-1.26M-2.21M-1.71M-2.35M-0.37M-2.08M-2.19M9.23M-4.30M-4.40M-3.86M-5.02M-3.17M0.06M3.55M1.31M0.06M
Income towards Parent CompanyParent Net Inc
-0.03M-0.73M-1.80M-1.26M-2.21M-1.71M-2.35M-0.37M-2.08M-2.19M9.23M-4.30M-4.40M-3.86M-5.02M-3.17M0.06M3.55M1.31M0.06M
Net Income towards Common StockholdersNet Income
-0.03M-0.73M-1.80M-1.26M-2.21M-1.71M-2.35M-0.37M-2.08M-2.19M9.23M-4.30M-4.40M-3.86M-5.02M-3.17M0.06M3.55M1.31M0.06M
Additional items
EPS (Basic)
0.00-0.01-0.02-0.01-0.03-0.02-0.030.00-0.02-0.020.07-0.04-0.03-0.03-0.04-0.020.000.030.010.00
EPS (Diluted)
0.00-0.01-0.02-0.01-0.03-0.02-0.030.00-0.02-0.020.07-0.03-0.03-0.03-0.04-0.020.000.020.010.00
Shares Outstanding
81.25M86.71M86.76M85.46M87.19M87.31M93.28M94.09M108.89M108.90M128.14M119.09M130.20M130.27M135.10M133.67M139.07M139.31M139.71M139.53M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
81.25M86.71M86.76M85.46M87.19M87.31M93.28M94.09M108.89M108.90M135.66M126.79M130.20M130.27M135.10M133.67M143.34M148.57M150.38M150.04M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
86.71M86.71M86.80M87.07M87.31M87.31M101.98M108.87M108.90M108.90M129.79M130.18M130.22M130.31M138.68M139.05M139.08M139.32M140.00M140.04M
EBITDA
-0.01M-0.49M-1.45M-1.91M-1.83M-1.30M-1.90M-1.72M-1.58M-1.39M-3.38M-3.81M-3.47M-2.95M-3.78M-1.88M1.06M4.62M2.54M2.32M
Interest ExpensesInt Expense
0.00M0.20M0.33M0.47M0.36M0.40M0.44M0.49M0.57M0.79M0.76M0.82M0.83M0.99M1.20M1.13M1.04M1.00M0.90M0.72M
Tax Rate
-383.33%-6.23%-1.69%46.78%-1.05%-0.77%-0.56%82.95%-0.63%-0.60%-33.18%-15.49%-1.57%-0.94%-1.25%-0.67%-75.76%6.70%16.42%96.43%